Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 2011; 106(02): 379-381
DOI: 10.1160/TH11-02-0066
DOI: 10.1160/TH11-02-0066
Letters to the Editor
Arterial and venous thrombosis and prothrombotic fibrin clot phenotype in a Polish family with type 1 antithrombin deficiency (antithrombin Krakow)
Financial support: This study has been supported by a grant of Jagiellonian University (no. K/ZDS/000565 to A.U.) and by the DHOS (Direction de l’Hospitalisation et de l’Organisation des Soins) program ″Soutien financier en faveur des laboratoires pratiquant le diagnostic par génétique moléculaire des maladies rares″ (to M.A.-G.).
Further Information
Publication History
Received: 02 February 2011
Accepted after major revision: 15 May 2011
Publication Date:
25 November 2017 (online)
-
References
- 1 Patnaik MM, Moll S. Inherited antithrombin deficiency: a review. Haemophilia 2008; 14: 1229-1239.
- 2 Sharpe CJ, Crowther MA, Webert KE. et al. Cerebral Venous Thrombosis During Pregnancy in the Setting of Type I Antithrombin Deficiency: Case Report and Literature Review. Transfus Med Rev 2011; 25: 61-65.
- 3 Lane DA, Bayston T, Olds RJ. et al. Antithrombin mutation database: 2nd (1997) update. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1997; 77: 197-211.
- 4 Picard V, Chen JM, Tardy B. et al. Detection and characterization of large SERPINC1 deletions in type I inherited antithrombin deficiency. Hum Genet 2010; 127: 45-53.
- 5 Finazzi G, Caccia R, Barbui T. Different prevalence of thromboembolism in the subtypes of congenital antithrombin III deficiency: review of 404 cases. Thromb Haemost 1987; 18: 1094.
- 6 Picard V, Nowak-Göttl U, Biron-Andreani C. et al. Molecular bases of antithrombin deficiency: twenty-two novel mutations in the antithrombin gene. Hum Mutat 2006; 27: 600.
- 7 Undas A, Zawilska K, Ciesla-Dul M. et al. Altered fibrin clot structure/function in patients with idio pathic venous thromboembolism and in their relatives. Blood 2009; 114: 4272-4278.
- 8 Lisman T, de Groot PG, Meijers JCM. et al. Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis. Blood 2005; 15: 1102-1105.
- 9 Wolf M, Boyer C, Tripodi A. et al. Antithrombin Milano: A new variant with monomeric and dimeric inactive antithrombin III. Blood 1985; 65: 496-500.
- 10 Scott EM, Ariëns RA, Grant PJ. Genetic and environmental determinants of fibrin structure and function: relevance to clinical disease. Arterioscler Thromb Vasc Biol 2004; 24: 1558-1566.
- 11 Wolberg AS. Thrombin generation and fibrin clot structure. Blood Rev 2007; 21: 131-142.
- 12 Campbell RA, Overmyer KA, Bagnell R. et al. Cellular procoagulant activity dictates clot structure and stability as a function of distance from the cell surface. Arterioscler Thromb Vasc Biol 2008; 28: 2247-2254.
- 13 Fatah K, Silveira A, Tornvall P. et al. Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age. Thromb Haemost 1996; 76: 535-540.
- 14 Jochmans K, Lissens W, Vervoort R. et al. Anti-thrombin-Gly 424 Arg: a novel point mutation responsible for type 1 antithrombin deficiency and neonatal thrombosis. Blood 1994; 83: 146-151.
- 15 Kuhle S, Lane DA, Johamanns A. et al. Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism. Thromb Haemost 2001; 86: 1007-1011.
- 16 Roldán V, Ordoñez A, Marín F. et al. Antithrombin Cambridge II (A384S) supports a role for antithrombin deficiency in arterial thrombosis. Thromb Haemost 2009; 101: 483-486.